|
Synonyms: example 20 [WO2019238616]
Compound class:
Synthetic organic
Comment: This compound is reported as an antagonist of the endosomal, nucleic acid activated Toll-like receptors (TLR) 7, 8, and 9 [2]. It is one of the chemical structures claimed in Hoffmann La Roche patent WO2019238616A1 [1].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Dey F, Kuo B, Liu H, Shen H, Wang X, Zhang W, Zhang Z, Zhu W. (2019)
Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune disease. Patent number: WO2019238616A1. Assignee: F Hoffmann La Roche AG, Hoffmann La Roche Inc. Priority date: 11/06/2019. Publication date: 19/12/2019. |
|
2. Zhang Z, Dey F, Liu H, Rudolph MG, Liu Y, Wang X, Zhang W, Zhang Z, Kou B, Zou G et al.. (2026)
Structure-Based Design of Potent TLR7/8/9 Triple Antagonists: Overcoming High Tissue Distribution and Reactive Metabolite Liabilities. J Med Chem, [Epub ahead of print]. [PMID:42484069] |